A survey on Visceral fat level in patients of Madhumeha (Type II Diabetes mellitus) and trial of Musta churna and Vrikshamla churna in its management

A Survey Study On Visceral Fat Level In Patients Of Madhumeha w.s.r To Type II Diabetes Mellitus And Randomised Comparative Therapeutic Trial Of Musta Churna And Vrikshamla Churna.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051917

Enrollment

Registered

2023-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: For Phase 1 1. Subjects who are known case of Type II Diabetes mellitus with FBS >126 mg/dl. 2. Subjects of age >18years and of either sex. For Phase 2 1. Mentally challenged subjects. 2. Uncooperative subjects. 3. Subjects known case of any other serious illness like Tuberculosis, Cardiac disorders, etc. 4. Subjects who are known case of Type I Diabetes mellitus. 5. Pregnant woman. 6. Lactating mother.

Exclusion criteria

Exclusion criteria: For Phase1( Survey study) 1. Mentally challenged subjects. 2. Uncooperative subjects. 3. Subjects known case of any other serious illness like Tuberculosis, Cardiac disorders, etc. 4. Subjects who are known case of Type I Diabetes mellitus. 5. Pregnant woman. 6. Lactating mother. For Phase 2( Clinical study) 1. Mentally challenged subjects. 2. Uncooperative subjects. 3. Subjects who are known case of any other serious illness like Tuberculosis, Cardiac disorders etc. 4. Subjects who are known case of Type I Diabetes mellitus. 5. Diabetic with history of Nephropathy, Retinopathy etc. 6. Subject who is under Insulin or Anti hyperglycaemic medications. 7. Pregnant woman. 8. Lactating mother.

Design outcomes

Primary

Measure	Time frame
Changes in Fasting Blood Sugar and Post Prandial Blood Sugar level. Timepoint: 45days	—

Secondary

Measure	Time frame
Changes in Visceral fat level, Lipid profile, Apolipoprotein b, and other disease specific symptoms of Madhumeha and Medodushti.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactProf Surendra Kumar Sharma

National Institute of Ayurveda , Jaipur

drsksm31@rediffmail.com9414361874

Outcome results